Form D · Other Investment Fund
Solas BioVentures Emerging Healthcare Fund, LP
Chattanooga, TN · CIK 0001940916
Offering snapshot reported May 21, 2024 · SEC filing
- Reported sold
- $35.2M Indefinite offering
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $1M Reported outside-investor minimum
- First sale
- Oct 21, 2022 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$20,150,000 → $35,150,000
- Reported investors3 → 26
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 21, 2024 | Amendment | $35,150,000 | $15,000,000vs May 19, 2023 | 26 | SEC filing |
| May 19, 2023 | Amendment | $20,150,000 | $14,400,000vs Nov 3, 2022 | 3 | SEC filing |
| Nov 3, 2022 | Initial | $5,750,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-463813
Source: Form D, filed May 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
SOLAS BIOVENTURES EMERGING HEALTHCARE FUND, LP
Investment adviser: SOLAS BIOVENTURES MANAGEMENT, LLC
- Gross asset value
- $48.6M
- Beneficial owners
- 55
- ADV minimum commitment
- $1M
Reported in Form ADV on Jul 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- No
- Administrator other than the adviser
- No
- External marketing
- No
LBMC, PC
PCAOB 450
Filing source
Form ADV 2123127 · Jul 30, 2026 · Schedule D 7.B.(1), fund 805-5029454480
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David C. Adair | Executive, Promoter |
| David Belitz | Executive, Promoter |
| Mark D. Hackett | Executive, Promoter |
| Michael Hoey | Executive, Promoter |
| N/A N/A Solas Bio Ventures Emerging Healthcare Gp, Llc | Promoter |
| N/A N/A Solas Bio Ventures Management, Llc | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Chattanooga, TN, 37403